NOX2

NOX2 (NADPH oxidase 2) is a catalytic member of the NADPH oxidase family that is specialized for reactive oxygen species (ROS) generation and serves as a central component of phagocyte antimicrobial defense and redox signaling pathways^[1][2]. NOX2 activation requires assembly of membrane and cytosolic regulatory subunits, enabling superoxide production at the plasma membrane or phagosomal membrane during immune responses^[2]. Mechanistically, NOX2-derived ROS contribute not only to pathogen killing but also to immune regulation, antigen presentation, and maintenance of self-tolerance, linking oxidative signaling to both innate and adaptive immunity^[3][4]. Dysregulated NOX2 activity has been implicated in multiple inflammatory and oxidative stress-associated disease models, while genetic deficiency of NOX2 causes chronic granulomatous disease characterized by impaired microbial killing and recurrent infections^[3][5]. In disease models, NOX2-derived ROS have been associated with inflammation, fibrosis, and cardiovascular pathology, highlighting the broad biological relevance of this isoform^[5][6]. Compared with related NOX isoforms, NOX2 is predominantly expressed in phagocytic cells, whereas NOX1, NOX3, NOX4, and NOX5 are primarily expressed in non-phagocytic tissues, indicating distinct physiological functions and cellular contexts^[7]. For experimental applications, NOX inhibitors and NOX2-targeted inhibitory peptides such as NOX2ds-tat have been used to investigate NOX2-dependent signaling; however, limited isoform selectivity remains an important consideration when interpreting pharmacological studies^[8].